Mon, September 30, 2024

Oren Livnat Reiterated (zvra) at Strong Buy and Held Target at $20 on, Sep 30th, 2024

Oren Livnat of HC Wainwright & Co., Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy and Held Target at $20 on, Sep 30th, 2024.

Oren has made no other calls on ZVRA in the last 4 months.



There are 5 other peers that have a rating on ZVRA. Out of the 5 peers that are also analyzing ZVRA, 0 agree with Oren's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Oren


  • Jason Butler of "JMP Securities" Initiated at Buy and Held Target at $17 on, Tuesday, September 24th, 2024
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 24th, 2024
  • Jonathan Aschoff of "Roth MKM" Maintained at Strong Buy with Increased Target to $21 on, Tuesday, September 24th, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024